Epilepsy appears to be the main reason for an increased risk of serious traffic accidents among patients with the disease —not anti-epileptic drugs.
Migraine is not characterized by neuronal degeneration, but it has been a target of stem cell therapy in a few small investigational studies--and has shown early promise.
This study points to nitrated nucleosomes as a promising biomarker for distinguishing neuropsychiatric events due to systemic lupus erythematosus from those secondary to other disorders.
Which medication should be avoided when your patient has an acute migraine? Which drugs should you prescribe for menstrual-associated migraine prevention? Take the quiz and learn more.
Dr. Wilner discusses 5 key points from a recent study on thrombectomy 6 to 16 hours after stroke.
Most people with Parkinson Disease develop cognitive impairment at some point. But this study provides evidence for sex differences in progression to cognitive impairment and dementia.
A newly synthesized compound may be the basis for a novel iron-chelation therapy in several iron-associated neurodegenerative disorders, including Alzheimer, Parkinson, and Huntington disease.
Children exposed to antiretrovirals (ARVs) may have worse neurodevelopmental outcomes than children never exposed to ARVs according to a systematic review and meta-analysis.
Starting antiretroviral therapy during the earliest phase of HIV infection may not be enough to prevent formation of viral reservoirs and enable cure or long-term ART-free HIV remission.
Clinicians should use caution when prescribing this medication in patients with heart disease because of risk of severe adverse effects and even death. Test your skills in this FDA quiz.
A large study evaluated exercise and its effects on cognitive function in patients with, or at risk for, Alzheimer disease.
Which brain regions are potential deep brain stimulation targets for neurological disorders with memory impairment? Take the quiz and learn more.
Do individuals hospitalized with head injury have new headaches or exacerbations of pre-existing headaches more often than others?
Although there is no cure for ALS, there are treatments available that can improve the quality of life and prolong survival.
Lower serum caffeine levels may be of diagnostic significance in early Parkinson disease, consistent with epidemiologic data that support the neuro-protective properties of caffeine.